Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer.
Malvina CremanteSilvia PuglisiAnnalice GandiniAntonio GuadagnoFabio CatalanoAlessandra DamassiVeronica MurianniMiguel Angel Llaja ObispoGiuseppe Luigi BannaSebastiano ButiSara Elena RebuzziPasquale RescignoGiuseppe FornariniPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
To our knowledge, this is one of the first cases of Apalutamide-related lichenoid reaction and this clinical case showed the relevance of a multidisciplinary management when assessing drug-related adverse events. A broader knowledge of the spectrum of drug-related reactions would allow for a better diagnosis and therapy management by both physicians and patients.
Keyphrases
- prostate cancer
- healthcare
- drug induced
- primary care
- squamous cell carcinoma
- end stage renal disease
- small cell lung cancer
- emergency department
- ejection fraction
- stem cells
- oxidative stress
- adverse drug
- radical prostatectomy
- patient reported
- smoking cessation
- patient reported outcomes
- mesenchymal stem cells
- diabetic rats